Logo image of CVV.CA

CANALASKA URANIUM LTD (CVV.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:CVV - CA13709C1005 - Common Stock

0.67 CAD
-0.07 (-9.46%)
Last: 1/8/2026, 7:00:00 PM
Fundamental Rating

2

Overall CVV gets a fundamental rating of 2 out of 10. We evaluated CVV against 214 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of CVV is average, but there are quite some concerns on its profitability. CVV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year CVV has reported negative net income.
CVV had a negative operating cash flow in the past year.
In the past 5 years CVV always reported negative net income.
In the past 5 years CVV always reported negative operating cash flow.
CVV.CA Yearly Net Income VS EBIT VS OCF VS FCFCVV.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -41.03%, CVV is doing worse than 76.17% of the companies in the same industry.
CVV has a worse Return On Equity (-50.02%) than 66.82% of its industry peers.
Industry RankSector Rank
ROA -41.03%
ROE -50.02%
ROIC N/A
ROA(3y)-52.11%
ROA(5y)-47.93%
ROE(3y)-61.88%
ROE(5y)-55.3%
ROIC(3y)N/A
ROIC(5y)N/A
CVV.CA Yearly ROA, ROE, ROICCVV.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CVV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CVV.CA Yearly Profit, Operating, Gross MarginsCVV.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

6

2. Health

2.1 Basic Checks

The number of shares outstanding for CVV has been increased compared to 1 year ago.
Compared to 5 years ago, CVV has more shares outstanding
CVV has a better debt/assets ratio than last year.
CVV.CA Yearly Shares OutstandingCVV.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CVV.CA Yearly Total Debt VS Total AssetsCVV.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

An Altman-Z score of 8.79 indicates that CVV is not in any danger for bankruptcy at the moment.
The Altman-Z score of CVV (8.79) is better than 90.65% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that CVV is not too dependend on debt financing.
CVV's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. CVV outperforms 77.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 8.79
ROIC/WACCN/A
WACCN/A
CVV.CA Yearly LT Debt VS Equity VS FCFCVV.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

2.3 Liquidity

CVV has a Current Ratio of 5.81. This indicates that CVV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.81, CVV belongs to the top of the industry, outperforming 89.72% of the companies in the same industry.
A Quick Ratio of 5.81 indicates that CVV has no problem at all paying its short term obligations.
The Quick ratio of CVV (5.81) is better than 89.72% of its industry peers.
Industry RankSector Rank
Current Ratio 5.81
Quick Ratio 5.81
CVV.CA Yearly Current Assets VS Current LiabilitesCVV.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

0

3. Growth

3.1 Past

CVV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -70.23%.
EPS 1Y (TTM)-70.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CVV will show a very negative growth in Earnings Per Share. The EPS will decrease by -35.40% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-63.33%
EPS Next 2Y-35.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CVV.CA Yearly EPS VS EstimatesCVV.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.02 -0.04 -0.06 -0.08 -0.1

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CVV. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CVV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVV.CA Price Earnings VS Forward Price EarningsCVV.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVV.CA Per share dataCVV.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1 0.15

4.3 Compensation for Growth

CVV's earnings are expected to decrease with -35.40% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-35.4%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CVV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CANALASKA URANIUM LTD

TSX-V:CVV (1/8/2026, 7:00:00 PM)

0.67

-0.07 (-9.46%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)12-17 2025-12-17/amc
Earnings (Next)03-23 2026-03-23
Inst Owners32.42%
Inst Owner ChangeN/A
Ins Owners4.02%
Ins Owner ChangeN/A
Market Cap140.64M
Revenue(TTM)N/A
Net Income(TTM)-15.94M
Analysts83.64
Price Target1.73 (158.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.36%
Min EPS beat(2)-45.63%
Max EPS beat(2)2.91%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)7.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-22.5%
EPS NY rev (3m)-22.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.41
P/tB 4.41
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -41.03%
ROE -50.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.11%
ROA(5y)-47.93%
ROE(3y)-61.88%
ROE(5y)-55.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.28%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.81
Quick Ratio 5.81
Altman-Z 8.79
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)125.08%
Cap/Depr(5y)290.51%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.61%
EPS Next Y-63.33%
EPS Next 2Y-35.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-42.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-57.08%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.62%
OCF growth 3YN/A
OCF growth 5YN/A

CANALASKA URANIUM LTD / CVV.CA FAQ

Can you provide the ChartMill fundamental rating for CANALASKA URANIUM LTD?

ChartMill assigns a fundamental rating of 2 / 10 to CVV.CA.


What is the valuation status of CANALASKA URANIUM LTD (CVV.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to CANALASKA URANIUM LTD (CVV.CA). This can be considered as Overvalued.


What is the profitability of CVV stock?

CANALASKA URANIUM LTD (CVV.CA) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for CVV stock?

The Earnings per Share (EPS) of CANALASKA URANIUM LTD (CVV.CA) is expected to decline by -63.33% in the next year.